These results suggest that altered PIP5K1c expression in adipocytes may play a role in the pathogenesis of certain metabolic diseases, such as type 2 diabetes, obesity, fatty liver and metabolic syndrome in humans. Here, PIP5K1C is linked to metabolic syndrome.